|Podcasts|December 1, 2011
Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them
Advertisement
Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them
Sam Whitaker, CEO of Greenphire, discusses the company’s success to date with its financial payments technology, global capabilities for next year, and how financial pressures are changing trials for the better.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5